Last update of the site:
Introduction NT-proBNP is the gold-standard biomarker for diagnosing and monitoring congestive heart failure (CHF); however, its role in detecting atrial fibrillation (AFib) is gaining attention. This study assessed the influence of aberrant cardiac rhythms on plasma NT-proBNP (pNT) considering urinary…
This study aimed to analyze risk factors for in-stent restenosis (ISR) following percutaneous coronary intervention (PCI) in patients with coronary heart disease and develop and validate a nomogram prediction model. Clinical data were retrospectively collected from 1135 patients with coronary…
Introduction Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis across an expanding risk spectrum. As indications extend to younger and lower-risk patients, post-treatment complications with implications for survival, quality of life, and valve durability…
Aortic stenosis (AS) is one of the most common valvular pathologies. Severe coronary artery disease (CAD) often coexists with AS. Transcatheter aortic valve implantation (TAVI) and percutaneous coronary intervention (PCI) have been established as alternatives to open surgical interventions. The…
